Seizures and Epilepsy After Ischemic Stroke

Background— Although a long-recognized clinical phenomenon, there remain many questions regarding the epidemiology of seizures and epilepsy after ischemic stroke, their effect on outcome, and their treatment.

Summary of Review— Interpretation of the various studies that have been conducted of postischemic stroke seizures and epilepsy are complicated by their heterogeneous designs, inconsistent uses of terminology, small sample sizes, different periods of follow-up, and ambiguities in seizure identification and classification. Estimates of the rate of early postischemic stroke seizures range from 2% to 33%. The rates of late seizures vary from 3% to 67%. The rate of postischemic stroke epilepsy is ≈2% to 4% and is higher in those who have a late seizure. Data reflecting seizure subtypes are limited. Aside from cortical location and, possibly, stroke severity, no other risk factors for postischemic stroke seizures have been consistently demonstrated. Results regarding the impact of postischemic stroke seizures on outcome are inconsistent.

Conclusions— Much additional work is needed to better understand the epidemiology and social impact of postischemic stroke seizures and epilepsy, their prevention, and optimal management.

Statewide Assessment of Hospital-Based Stroke Prevention and Treatment Services in North Carolina

Background and Purpose— The first published statewide assessment of stroke prevention and treatment services in the United States was carried out in North Carolina in 1998. The purpose of the present study was to measure changes in these services that may have occurred over the last 5 years.

Methods— A 1-page questionnaire was sent to each facility in the state in February 2003. Results were compared with the 1998 survey.

Results— Complete responses were obtained from each of the state’s 128 facilities. The proportions of hospitals providing CT angiography (35% versus 55%, P ≤0.01), diffusion-weighted MRI (20% versus 45%, P ≤0.01), transesophageal echocardiography (45% versus 59%, P ≤0.02), and inpatient rehabilitation services (25% versus 43%, P ≤0.01) increased over the 5 years. There was a trend toward more facilities having tissue plasminogen activator protocols (43% versus 54%, P ≤0.09) but a decrease in the proportion of hospitals with interventional radiologists (23% versus 15%, P <0.01). There was no change in the proportion of the state’s population living in a county with a basic stroke prevention and treatment center, with the proportion residing in a county with an advanced center increasing by 12%. Entire regions of the state lacked either type of center, and only 14% had even the essential infrastructure recommended for a Brain Attack Coalition–type primary stroke center. There was no difference in the proportions of hospitals with organized stroke teams, those having a stroke acute care unit, those using stroke care maps, or hospitals having community awareness programs.

Conclusions— Certain technologies have become more widely available, but hospital investments in stroke-related programs have not appreciably increased.

Non-Atherosclerotic Vascular Disease in the Young

There are a large variety of non-atherosclerotic causes of ischemic stroke in the young. Arterial dissection, most commonly associated with non-traumatic causes, is among the most common. Both the carotid and vertebrobasilar circulations can be affected. The vasculitidies represent a rare, but potentially treatable series of conditions that can lead to stroke through diverse mechanisms. Moyamoya is a nonatherosclerotic, noninflammatory, nonamyloid vasculopathy characterized by chronic progressive stenosis or occlusion of the distal internal carotid arteries and/or proximal portions of the middle and/or anterior cerebral arteries. Moyamoya can be idiopathic (moyamoya disease) or the result of other conditions. An appreciation of the unusual causes of stroke in the young is important when considering secondary prevention measures.